文献速递主动脉疾病颈动脉与弓上血管外周动脉疾病

《平价医疗法案》实施前后血管外科手术与血管实验室检查的医生报销对比

Physician Reimbursement for Vascular Surgery Procedures and Vascular Laboratory Studies Before and After the Affordable Care Act.
PubMed 文献 · Ann Vasc Surg · 2021-11-12

本研究比较了《平价医疗法案》(ACA)实施前后(2008年1月至2009年12月 vs 2015年1月至2016年12月)本机构5项血管外科手术和4项血管实验室检查的医生报销。分析了1,637例手术和16,333项检查。结果显示,多数血管外科手术的Medicare和Medicaid报销未跟上通胀,而多数血管实验室检查的报销超过通胀。

要点

  • ACA实施后,多数血管外科手术的Medicare和Medicaid医生报销低于通胀调整后金额。
  • ACA实施后,多数血管实验室检查的医生报销高于通胀调整后金额(Medicare除外)。

核心结论

  • 比较ACA实施前后,多数血管外科手术的Medicare和Medicaid医生报销未跟上通胀,而多数血管实验室检查的医生报销超过通胀。
  • 需要进一步努力支持血管外科报销,包括提高Medicare转换因子的估值。

研究设计与样本

  • 从本机构计费部门获取5项血管外科手术(CPT 34803、35301、35656、36010、36200 first)和4项血管实验室检查(CPT 93922、93925、93970、93990)的医生报销数据。
  • 按支付方(Medicare、Medicaid、商业保险、其他)分类,比较ACA前(2008年1月至2009年12月)与ACA后(2015年1月至2016年12月)的报销,并使用2016年美元消费者价格指数进行通胀调整,采用单样本t检验。
  • 分析了1,637例血管外科手术和16,333项血管实验室检查的报销数据。

主要发现

  • 对于EVAR,ACA后报销总体与通胀调整后金额持平,但Medicare显著较低。
  • 对于CEA,ACA后报销总体低于通胀调整后金额;对于LEB,总体平均医生报销低于通胀调整后金额,其中Medicare和Medicaid支付显著较低(P < 0.001)。
  • 对于ICVC(原文写作ICAo),ACA后总体医生报销显著低于通胀调整后金额,且在所有保险类型中均如此。
  • 对于ICV,ACA后报销在所有支付方中均高于通胀调整后金额,但未达统计学显著(P = 0.25)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The Patient Protection and Affordable Care Act (ACA), fully implemented by 2015, has significantly increased the number of Americans with health insurance. However, its impact on physician reimbursement (PR) is not well studied. Our objective was to determine the ACA's impact on the professional component of PR for selected vascular surgery (VS) procedures and vascular laboratory (VL) studies at our institution. METHODS: PR for the following 5 VS procedures and 4 VL studies were obtained from our billing department: CPT 34803 (Endovascular aortic repair, EVAR), 35301 (carotid endarterectomy, CEA), 35656 (lower extremity bypass, LEB), 36010 (introduction of catheter into vena cava, ICVC), 36200 first, 93922 (ankle brachial index, ABI), 93925 (lower extremity arterial duplex, LEA duplex), 93970 (lower extremity venous duplex, LEV Duplex), and 93990 (hemodialysis duplex). The data was organized by payer: Medicare, Medicaid, Commercial Insurers (CI), and Other. PR was studied pre-ACA (January 2008 through December 2009) and post-ACA (January 2015 through December 2016). The post-ACA PR and inflation adjusted reimbursement (IAR) in 2016 dollars using the consumer price index (CPI) were calculated and compared using one-sample t-test. The percent difference between the post-ACA PR and IAR was also compared. RESULTS: PR for 1,637 VS procedures and 16,333 VL studies was analyzed. The post-ACA PR was significantly lower than the IAR for most Medicare and Medicaid procedures. For EVAR, post-ACA reimbursement was overall on par with the IAR but significantly lower for Medicare. For CEA, post-ACA reimbursement was overall lower than IAR. For LEB, overall average PR was lower than IAR, with statistically significant lower Medicare and Medicaid (P < 0.001) payments. For ICAo, overall PR was significantly lower than the IAR and this was true across all insurance types. In contrast, for ICV, the post-ACA reimbursement was higher than IAR for all payers but did not reach statistical significance (P = 0.25). The post-ACA PR was significantly higher than the IAR for most VL studies, except for Medicare PR. The percent change for VS procedures were mostly negative for the Medicaid and Medicare groups. This results in potential annual shortcomings of $2, 862 and $20,923 respectively. CONCLUSION: When comparing reimbursement before and after ACA implementation, Medicare and Medicaid PR for most VS procedures has not kept up with inflation. However, for most VL procedures, PR has exceeded inflation. Further efforts are needed to support Vascular Surgery reimbursement including higher valuation of the Medicare Conversion factor.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Haurani MJ, Chou D, Vaccaro PS, et al. Physician Reimbursement for Vascular Surgery Procedures and Vascular Laboratory Studies Before and After the Affordable Care Act. Ann Vasc Surg. 2021. PMID: 34780946. doi:10.1016/j.avsg.2021.09.051

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。